Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Drug Delivery

Beam acquires LNP company Guide Therapeutics for $120 million

by Ryan Cross
February 26, 2021 | A version of this story appeared in Volume 99, Issue 7

 

The gene-editing company Beam Therapeutics has acquired the lipid nanoparticle (LNP) discovery firm Guide Therapeutics for $120 million up front and up to $320 million in milestone payments. Guide was founded in 2018 based on the work of Georgia Institute of Technology biomedical engineer James Dahlman and former graduate student Cory Sago. The start-up uses DNA bar codes to test hundreds of LNPs at a time for their ability to deliver genes to different cells and tissues.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.